A Review and Update on Clinical Management on Burning Mouth Syndrome

Burning Mouth Syndrome (BMS) is a chronic illness that typically affects middle-aged women after menopause. This sickness is identified by the absence of clinical signs and burning sensations in the oral mucosa. The aetiology of BMS is complex, involving a variety of factors. Stress, worry, and depression are just a few of the local, systemic, and psychological disorders that can induce BMS. Types I, II, and III of the BMS are plausible categories. Despite the fact that there are no visible organic changes or health risks linked with this illness, it can have a significant impact on the patient’s quality of life. The goal of this paper is to evaluate the available literature on BMS, with a focus on therapeutic management. Important diagnostic criteria, etiological variables, and clinical characteristics will also be discussed in the sections that follow. The major goal of care is to provide support to the patient and work toward symptom reduction rather than complete symptom removal. The most commonly utilised therapy options include tricyclic antidepressants, benzodiazepines, and antipsychotic medications, which have varying effectiveness; however, other therapies will be provided that can also be used. Professionals should handle this group of patients, explaining and reaffirming the nature of the disease and discussing the benefits of proposed medicines or the likelihood of pain relief. Patients should be informed about the importance of working with a multidisciplinary team and the possibility of needing many therapy adjustments before achieving effective treatment. Dental professionals should provide standardised symptoms and diagnostic criteria so that multidisciplinary research can more easily identify the most effective and reliable BMS treatment options.

Author (S) Details

Juliana Cassol Spanemberg
University Fernando Pessoa-Canarias, Spain.

Eugenia Rodríguez de Rivera Campillo
Faculty of Medicine and Health Sciences (Dentistry). Oral Health and Masticatory System Group IDIBELL (Bellvitge Biomedical Research Institute). University of Barcelona, Spain.

Enric Jané Salas
Faculty of Medicine and Health Sciences (Dentistry). Oral Health and Masticatory System Group IDIBELL (Bellvitge Biomedical Research Institute). University of Barcelona, Spain.

Albert Estrugo Devesa
Faculty of Medicine and Health Sciences (Dentistry). Oral Health and Masticatory System Group IDIBELL (Bellvitge Biomedical Research Institute). University of Barcelona, Spain.

José López López
Faculty of Medicine and Health Sciences (Dentistry). Oral Health and Masticatory System Group IDIBELL (Bellvitge Biomedical Research Institute). University of Barcelona, Spain.

View Book :- https://stm.bookpi.org/NFMMR-V16/article/view/3798

Leave a Reply

Your email address will not be published. Required fields are marked *